What is RPID's current stock price?

RPID (Rapid Micro Biosystems, Inc.) is currently trading at $2.05 with a market cap of $92.9M.

What sector is Rapid Micro Biosystems, Inc. in?

Rapid Micro Biosystems, Inc. (RPID) operates in the Healthcare sector, specifically in the Medical - Devices industry.

Is RPID a good stock to buy?

Analysts have a Buy consensus on RPID with a price target of $7.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

RPID Rapid Micro Biosystems, Inc.

Healthcare

$2.05-0.97%ClosedMarket Cap: $92.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

4.57

P/S

2.70

EV/EBITDA

-2.21

DCF Value

$-16.50

FCF Yield

-39.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

12.4%

Operating Margin

-144.2%

Net Margin

-145.8%

ROE

-131.5%

ROA

-80.4%

ROIC

-111.3%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$8.0M	$-14.3M	$—
Q4 null	$11.3M	$-12.5M	$—
FY null	$33.6M	$-47.1M	$—
Q3 null	$7.8M	$-11.5M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$7.00

Target (Median)

$7.00

Target Range

$7.00 - $7.00

0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Lake StreetBuy

2026-05-22

Trading Activity

Insider Trades

View All

Bain Capital Life Sciences Investors, LLC10 percent owner

BuyFri May 22

WIRTJES SEAN Mofficer: CHIEF FINANCIAL OFFICER

SellThu Mar 12

Wilson John J. Addingtonofficer: CHIEF OPERATING OFFICER

SellThu Mar 12

Spignesi Robert G. Jr.director, officer: PRESIDENT AND CEO

SellThu Mar 12

RICCIARDI NATALE Sdirector

SellMon Mar 02

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

Exchange

—

Beta

1.53

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Peers